106 related articles for article (PubMed ID: 33751940)
1. Comparison of human and rodent cell models to study myocardial lipid-induced insulin resistance.
Wong LY; Glatz JFC; Wang S; Geraets IME; Vanherle S; Wijngaard AVD; Brunner H; Luiken JJFP; Nabben M
Prostaglandins Leukot Essent Fatty Acids; 2021 Apr; 167():102267. PubMed ID: 33751940
[TBL] [Abstract][Full Text] [Related]
2. Human embryonic stem cell-derived cardiomyocytes as an in vitro model to study cardiac insulin resistance.
Geraets IME; Chanda D; van Tienen FHJ; van den Wijngaard A; Kamps R; Neumann D; Liu Y; Glatz JFC; Luiken JJFP; Nabben M
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1960-1967. PubMed ID: 29277329
[TBL] [Abstract][Full Text] [Related]
3. Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay.
Nose N; Werner RA; Ueda Y; Günther K; Lapa C; Javadi MS; Fukushima K; Edenhofer F; Higuchi T
Int J Cardiol; 2018 Oct; 269():229-234. PubMed ID: 30224033
[TBL] [Abstract][Full Text] [Related]
4. Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.
Gentillon C; Li D; Duan M; Yu WM; Preininger MK; Jha R; Rampoldi A; Saraf A; Gibson GC; Qu CK; Brown LA; Xu C
J Mol Cell Cardiol; 2019 Jul; 132():120-135. PubMed ID: 31082397
[TBL] [Abstract][Full Text] [Related]
5. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
[TBL] [Abstract][Full Text] [Related]
6. Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes.
Horikoshi Y; Yan Y; Terashvili M; Wells C; Horikoshi H; Fujita S; Bosnjak ZJ; Bai X
Cells; 2019 Sep; 8(9):. PubMed ID: 31533262
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
[TBL] [Abstract][Full Text] [Related]
8. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
Ting S; Chen A; Reuveny S; Oh S
Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
[TBL] [Abstract][Full Text] [Related]
9. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy.
Knight WE; Cao Y; Lin YH; Chi C; Bai B; Sparagna GC; Zhao Y; Du Y; Londono P; Reisz JA; Brown BC; Taylor MRG; Ambardekar AV; Cleveland JC; McKinsey TA; Jeong MY; Walker LA; Woulfe KC; D'Alessandro A; Chatfield KC; Xu H; Bristow MR; Buttrick PM; Song K
Stem Cell Reports; 2021 Mar; 16(3):519-533. PubMed ID: 33636116
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J
Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214
[TBL] [Abstract][Full Text] [Related]
11. Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.
Prajapati C; Ojala M; Aalto-Setälä K
Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29361520
[TBL] [Abstract][Full Text] [Related]
12. Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes.
Ulmer BM; Stoehr A; Schulze ML; Patel S; Gucek M; Mannhardt I; Funcke S; Murphy E; Eschenhagen T; Hansen A
Stem Cell Reports; 2018 Mar; 10(3):834-847. PubMed ID: 29503093
[TBL] [Abstract][Full Text] [Related]
13. GLUT4 expression and glucose transport in human induced pluripotent stem cell-derived cardiomyocytes.
Bowman PRT; Smith GL; Gould GW
PLoS One; 2019; 14(7):e0217885. PubMed ID: 31344028
[TBL] [Abstract][Full Text] [Related]
14. Dynamic link between histone H3 acetylation and an increase in the functional characteristics of human ESC/iPSC-derived cardiomyocytes.
Otsuji TG; Kurose Y; Suemori H; Tada M; Nakatsuji N
PLoS One; 2012; 7(9):e45010. PubMed ID: 22984602
[TBL] [Abstract][Full Text] [Related]
15. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
16. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
[TBL] [Abstract][Full Text] [Related]
17. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
Yang X; Papoian T
J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
[TBL] [Abstract][Full Text] [Related]
18. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
[TBL] [Abstract][Full Text] [Related]
19. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
Liao S; Zhang Y; Ting S; Zhen Z; Luo F; Zhu Z; Jiang Y; Sun S; Lai WH; Lian Q; Tse HF
Stem Cell Res Ther; 2019 Mar; 10(1):78. PubMed ID: 30845990
[TBL] [Abstract][Full Text] [Related]
20. Studying KCNQ1 Mutation and Drug Response in Type 1 Long QT Syndrome Using Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Wei H; Wu J; Liu Z
Methods Mol Biol; 2018; 1684():7-28. PubMed ID: 29058180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
